Similar articles

• A pregnancy-prevention program in women of childbearing age receiving isotretinoin.

  Mitchell AA, Van Bennekom CM, Louik C. Mitchell AA, et al. N Engl J Med. 1995 Jul 13;333(2):101-6. doi: 10.1056/NEJM199507133330206. N Engl J Med. 1995. PMID: 7777014
• Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.

  Brinker A, Kornegay C, Nourjah P. Brinker A, et al. Arch Dermatol. 2005 May;141(5):563-9. doi: 10.1001/archderm.141.5.563. Arch Dermatol. 2005. PMID: 15897377
• [Isotretinoin in childbearing women: compliance with strengthen warnings].

  Autret-Leca E, Jonville-Béra AP, Szafir D, Cissoko H, Boulkroun Y, Goehrs JM. Autret-Leca E, et al. Ann Dermatol Venereol. 2000 Oct;127(10):808-13. Ann Dermatol Venereol. 2000. PMID: 11060382 French.
• [Treatment of acne by isotretinoin (general course)].

  Chivot M. Chivot M. Rev Prat. 2002 Apr 15;52(8):845-9. Rev Prat. 2002. PMID: 12053792 Review. French.
• Drugs in pregnancy.

  Koren G, Pastuszak A, Ito S. Koren G, et al. N Engl J Med. 1998 Apr 16;338(16):1128-37. doi: 10.1056/NEJM199804163381607. N Engl J Med. 1998. PMID: 9545362 Review. No abstract available.